Merck CEO Davis, R&D head Li to speak at Morgan Stanley Global Healthcare Conference
MRK•Conference participation
- Merck will join Morgan Stanley’s 24th Annual Global Healthcare Conference on Sept. 14, 2026.
- CEO Robert M. Davis will take part in a fireside chat at 3:20 p.m. ET.
- Merck Research Laboratories head Dean Y. Li will also participate in the session.
